| Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation E Bulatov, A Ciulli Biochemical Journal 467 (3), 365-386, 2015 | 220 | 2015 |
| The biological basis and clinical symptoms of CAR-T therapy-associated toxicites A Titov, A Petukhov, A Staliarova, D Motorin, E Bulatov, O Shuvalov, ... Cell death & disease 9 (9), 897, 2018 | 119 | 2018 |
| Application of CAR-T cell therapy beyond oncology: autoimmune diseases and viral infections E Zmievskaya, A Valiullina, I Ganeeva, A Petukhov, A Rizvanov, E Bulatov Biomedicines 9 (1), 59, 2021 | 85 | 2021 |
| Advancing CAR T-cell therapy for solid tumors: lessons learned from lymphoma treatment A Titov, A Valiullina, E Zmievskaya, E Zaikova, A Petukhov, R Miftakhova, ... Cancers 12 (1), 125, 2020 | 75 | 2020 |
| Adoptive immunotherapy beyond CAR T-cells A Titov, E Zmievskaya, I Ganeeva, A Valiullina, A Petukhov, ... Cancers 13 (4), 743, 2021 | 74 | 2021 |
| Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option? R Mirgayazova, R Khadiullina, V Chasov, R Mingaleeva, R Miftakhova, ... Genes 11 (6), 704, 2020 | 46 | 2020 |
| Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors E Bulatov, R Sayarova, R Mingaleeva, R Miftakhova, M Gomzikova, ... Cell Death Discovery 4 (1), 103, 2018 | 43 | 2018 |
| Key Players In The Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy V Chasov, R Mirgayazova, E Zmievskaya, R Khadiullina, A Valiullina, ... Frontiers in Oncology 10, 1460, 2020 | 38 | 2020 |
| Knowns and unknowns about CAR-T cell dysfunction A Titov, Y Kaminskiy, I Ganeeva, E Zmievskaya, A Valiullina, ... Cancers 14 (4), 1078, 2022 | 37 | 2022 |
| Small molecule modulators of RING-type E3 ligases: MDM and Cullin families as targets E Bulatov, A Zagidullin, A Valiullina, R Sayarova, A Rizvanov Frontiers in pharmacology 9, 450, 2018 | 35 | 2018 |
| Discovery of nanomolar-affinity pharmacological chaperones stabilizing the oncogenic p53 mutant Y220C JR Stephenson Clarke, LR Douglas, PJ Duriez, DI Balourdas, AC Joerger, ... ACS pharmacology & translational science 5 (11), 1169-1180, 2022 | 32 | 2022 |
| Promising new tools for targeting p53 mutant cancers: Humoral and cell-based immunotherapies V Chasov, M Zaripov, R Mirgayazova, R Khadiullina, E Zmievskaya, ... Frontiers in Immunology 12, 707734, 2021 | 30 | 2021 |
| Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases E Bulatov, A Valiullina, R Sayarova, A Rizvanov Immunology Letters 202, 44-51, 2018 | 30 | 2018 |
| Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2) E Bulatov, EM Martin, S Chatterjee, A Knebel, S Shimamura, ... Journal of Biological Chemistry 290 (7), 4178-4191, 2015 | 30 | 2015 |
| Binding and purification of plasmid DNA using multi-layered carbon nanotubes II Shakhmaeva, ER Bulatov, OV Bondar, DV Saifullina, M Culha, ... Journal of biotechnology 152 (3), 102-107, 2011 | 30 | 2011 |
| Effect of size and protein environment on electrochemical properties of gold nanoparticles on carbon electrodes TI Abdullin, OV Bondar, II Nikitina, ER Bulatov, MV Morozov, ... Bioelectrochemistry 77 (1), 37-42, 2009 | 30 | 2009 |
| Novel approaches for the rational design of PROTAC linkers A Zagidullin, V Milyukov, A Rizvanov, E Bulatov Exploration of Targeted Anti-tumor Therapy 1, 381-390, 2020 | 29 | 2020 |
| Evaluation of CAR-T cells’ Cytotoxicity against modified solid tumor cell lines AK Valiullina, EA Zmievskaya, IA Ganeeva, MN Zhuravleva, EE Garanina, ... Biomedicines 11 (2), 626, 2023 | 25 | 2023 |
| Recent advances in the development of bioreactors for manufacturing of adoptive cell immunotherapies I Ganeeva, E Zmievskaya, A Valiullina, A Kudriaeva, R Miftakhova, ... Bioengineering 9 (12), 808, 2022 | 25 | 2022 |
| Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion Y Kaminskiy, V Kuznetsova, A Kudriaeva, E Zmievskaya, E Bulatov Frontiers in Immunology 13 (971045), 1-8, 2022 | 25 | 2022 |
Albert RizvanovKazan Federal University在 kpfu.ru 的电子邮件经过验证
